Brind.
  1. Major tech companies like Microsoft, Google, Amazon, and OpenAI are heavily investing in and competing within the AI revolution.
  2. Trump-era tariffs may benefit AI stocks, while Google faces DOJ rulings and secures a default search engine deal with Apple.
  3. AI stocks are benefiting from the trend of onshoring and tariffs implemented during the Trump era.
  4. Paige, acquired by Tempus AI, has received FDA clearance, while AI stocks continue to benefit from onshoring and tariff trends.

Tempus AI, led by Eric Lefkofsky, is acquiring Paige to enhance its digital pathology datasets.

2 reports, 2 independent Updated Aug 25
Gone quiet Reached 2 outlets in its first 24 hours
Reports
2
Developments
2
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Tempus AI, led by Eric Lefkofsky, is acquiring Paige to enhance its digital pathology datasets.

Who's involved

What this event is mainly about
PaigeTempus

How it developed

Newest first. Tap a step to see who reported it.
  1. Leica Biosystems integrates products from Paige and Tempus AI into its platform, adding Paige products to its AI Store.Sub-event
  2. Tempus AI is integrating Paige's digital pathology datasets to bolster its AI capabilities.1 source

Keep exploring

Part of

Paige, acquired by Tempus AI, has received FDA clearance, while AI stocks continue to benefit from onshoring and tariff trends. All 1 developments

Within Major tech companies like Microsoft, Google, Amazon, and OpenAI are heavily investing in and competing within the AI revolution.

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • Medical Device NetworkTempus to acquire AI digital pathology company Paige Technology company Tempus AI has announced the acquisition of Paige, a company focused on digital pathology and AI, for a total of $81.25m. The tr
  • Business WireTempus Announces the Acquisition of Paige Paige’s strong foundation in pathology and AI is rooted in its proprietary dataset of almost 7 million digitized pathology slides that are clinically annotat